Enanta Pharmaceuticals reported $311.71M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US USD 24.06B 4.74B
Anika Therapeutics ANIK:US USD 167.76M 95K
Arrowhead Research ARWR:US USD 432.39M 14.76M
AstraZeneca AZN:LN USD 20.22B 693M
Biogen BIIB:US USD 9.77B 24.9M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Clovis Oncology CLVS:US USD 102.21M 40.07M
Enanta Pharmaceuticals ENTA:US USD 311.71M 1.32M
Gilead Sciences GILD:US USD 13.9B 723M
GlaxoSmithKline GSK:LN GBP 20.25B 33.94B
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Insmed INSM:US USD 632.16M 42.56M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
Karyopharm Therapeutics KPTI:US USD 222.68M 19.77M
Ligand Pharmaceuticals LGND:US USD 220.43M 23.35M
Marinus Pharmaceuticals MRNS:US USD 177.01M 75.91M
Neurocrine Biosciences NBIX:US USD 1.21B 186.2M
Novartis NOVN:VX USD 36.95B 1.19B
Novavax NVAX:US USD 1.76B 376.04M
Ptc Therapeutics PTCT:US USD 517.26M 177.41M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Vertex Pharmaceuticals VRTX:US USD 12.27B 767.5M
Vital Therapies VTL:US USD 86.65M 18.11M
YTE INCY:US USD 3.82B 195.27M